用新的抗病毒疗法治疗乙型肝炎病毒的功能治疗:系统性审查和元分析
Jing Chen1, Dong Ji2, Jidong Jia3
1School of Public Health and Primary Care, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong SAR, China. jingchen001@cuhk.edu.hk.
Hepatology international
|June 17, 2025
概括
慢性乙型肝炎 (HBV) 的新型抗病毒治疗方法在实现功能治愈或HBsAg损失方面取得的成功极小. 未来的研究必须解决改善HBV患者治疗疗效的障碍.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 临床试验 临床试验
背景情况:
- 慢性乙型肝炎 (HBV) 功能治愈是关键的治疗目标.
- 新型抗病毒疗法正在开发中,以实现这种治疗.
- 功能治疗的障碍需要识别和理解.
研究的目的:
- 评估慢性乙型肝炎新型抗病毒治疗方法的疗效和安全性.
- 确定阻碍HBV功能治愈的新兴障碍.
主要方法:
- 针对HBV.gov在clinicaltrials.gov上注册的2018-2023年临床试验的系统综述.
- 对19项研究的元分析,包括1789名非肝炎HBV患者.
- 主要结局:功能治愈率;次要结局:HBsAg水平,HBsAg损失,HBV DNA反弹,不良事件.
主要成果:
- 最低的功能治愈率 (0.0%) 和低的HBsAg损失率 (0.9%在EOT,0.1%在EOF).
- 暂时的HBsAg水平下降没有持续;20.5%的病毒学复发治疗后.
- 新型治疗耐受性良好,但与较高的不良事件率相关 (OR=1.77).
结论:
- 新型抗病毒疗法在HBV功能治愈和HBsAg损失方面表现出有限的有效性.
- 显著的障碍,包括复杂的试验设计,阻碍了实现功能治疗的进展.
- 进一步的研究是克服这些挑战和增强HBV治疗策略的必要条件.
关键词:
不良事件是不良事件.障碍物 这些障碍物慢性乙型肝炎 慢性乙型肝炎混的因素是混的因素.这就是HBV的DNA.导致HBsAg的损失.减少HBsAg的减少恢复免疫系统的恢复治疗终点治疗终点病毒学复发病毒学复发cccDNADNA 在线阅读更多相关视频
相关概念视频
Retrovirus Life Cycles
47.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
47.0K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
561
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
561
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Subviral Agents
130
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
130
Retroviruses
12.7K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.7K


